Introduction {#s1}
============

*Anaplasma phagocytophilum* (Rickettsiales: Anaplasmataceae) is an obligate intracellular bacterium mainly transmitted by *Ixodes* spp. ticks. This emerging pathogen has been reported in the United States, Europe, Africa, and Asia (de la Fuente et al., [@B18]; Stuen et al., [@B40]; Kocan et al., [@B29]), causing human granulocytic anaplasmosis (HGA), equine and canine granulocytic anaplasmosis and tick-borne fever (TBF) of ruminants (de la Fuente et al., [@B18]; Stuen et al., [@B40]; Kocan et al., [@B29]).

The development of *A. phagocytophilum* is complex and coordinated with the tick feeding cycle. Infection and multiplication in ticks occurs first in midgut cells during blood feeding, and then subsequently in other tissues including hemocytes and salivary glands from where transmission occurs to susceptible hosts (Kocan et al., [@B29]). To establish infection, *A. phagocytophilum* affect mechanisms that appear to be common to ticks and vertebrate hosts (de la Fuente et al., [@B17]). These mechanisms include but are not limited to remodeling of the cytoskeleton, inhibition of cell apoptosis, manipulation of the immune response, and modification of cell epigenetics and metabolism (de la Fuente et al., [@B17]).

Recently, transcriptomics, proteomics and metabolomics analyses of infected *I. scapularis* ISE6 cells showed that *A. phagocytophilum* infection affects glucose metabolic pathways (Villar et al., [@B42]). These results suggested that *A. phagocytophilum* manipulate carbohydrate metabolism to facilitate infection and multiplication in tick cells. However, the mechanisms used by *A. phagocytophilum* for the manipulation of carbohydrate metabolic pathways have not been fully characterized.

To better characterize the mechanisms used by *A. phagocytophilum* to manipulate carbohydrate metabolic pathways during infection of tick cells, the dynamics of the carbohydrate metabolism was characterized in the tick vector, *I. scapularis* in response to pathogen infection. First, the composition of major carbohydrate metabolic pathways was annotated using the recently published genome of *I. scapularis* (Gulia-Nuss et al., [@B26]). Then, previously published transcriptomics and proteomics data (Ayllón et al., [@B6]; Villar et al., [@B42]) was used to characterize the mRNA and protein levels of carbohydrate metabolic pathway components in response to *A. phagocytophilum* infection of *I. scapularis* nymphs, female midguts and salivary glands, and ISE6 cultured tick cells. Finally, functional studies were conducted in ISE6 tick cells to provide additional support for the role of these components during pathogen infection. These results expanded our knowledge of the different pathways affected by *A. phagocytophilum* infection in ticks, and provided new potential targets for the development of therapeutic and prevention strategies for the control of granulocytic anaplasmosis and other tick-borne diseases.

Materials and methods {#s2}
=====================

Annotation of the major carbohydrate metabolic pathway components in the *I. scapularis* genome
-----------------------------------------------------------------------------------------------

The *I. scapularis* genome (Gulia-Nuss et al., [@B26]) was searched with the specific names of genes encoding for enzymes involved in the major carbohydrate metabolic pathways, glycolysis, gluconeogenesis, pentose phosphate, tricarboxylic acid cycle (TCA), glyceroneogenesis, and mitochondrial oxidative phosphorylation and β-oxidation. When records were not obtained using specific enzyme names, then the *I. scapularis* genome was searched with the Blastp tool from the Basic Local Alignment Search Tool (BLAST) using the human ortholog as "query" (Altschul et al., [@B1]; Madden et al., [@B33]). The sequences with the lowest *E*-value were selected. The conserved domains of identified protein sequences were classified using the protein families database Pfam (Finn et al., [@B25]). The *I. scapularis* orthologs found in the genome were double-checked by searching the *Homo sapiens* genome database using as queries the tick homologs identified in the previous step.

Characterization of the *I. scapularis* mRNA and protein levels in response to *A. phagocytophilum* infection
-------------------------------------------------------------------------------------------------------------

The quantitative transcriptomics and proteomics data for uninfected and *A. phagocytophilum*-infected *I. scapularis* nymphs, female midguts and salivary glands, and ISE6 cultured cells were obtained from previously published results (Ayllón et al., [@B6]; Villar et al., [@B42]) and deposited at the Dryad repository database, NCBI\'s Gene Expression Omnibus database and ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier [PXD002181](PXD002181) and doi: 10.6019/PXD002181. For transcriptomics and proteomics analysis in *I. scapularis* nymphs, female midguts and salivary glands, the procedures were described in Ayllón et al. ([@B6]). Briefly, nymphs and adult female *I. scapularis* were infected with *A. phagocytophilum* by feeding on a sheep inoculated intravenously with \~1 × 10^7^ *A. phagocytophilum* (NY18 isolate)-infected HL-60 cells (90--100% infected cells). In this model, over 85% of ticks become infected with *A. phagocytophilum* in nymphs, midguts and salivary glands. Ticks (200 nymphs and 100 female adults) were removed from the sheep 7 days after infestation, held in the humidity chamber for 4 days and dissected for DNA, RNA, and protein extraction from whole internal tissues (nymphs) or midguts and salivary glands (adult females). Adult midguts and salivary glands were washed in PBS after collection to remove hemolymphs-related cells. Uninfected ticks were prepared in a similar way but feeding on an uninfected sheep. Two independent samples were collected and processed for each tick developmental stage and tissue. After RNA sequencing on an Illumina Hiseq 2000, TopHat was used to align the reads to the *I. scapularis* (assembly JCVI_ISG_i3_1.0; <http://www.ncbi.nlm.nih.gov/nuccore/NZ_ABJB000000000>) reference genome. Raw counts per gene were estimated by the Python script HTSeq count \[<http://www-huber.embl.de/users/anders/HTSeq/>\] using the reference genome. The raw counts per gene were used by DEGseq to estimate differential expression at *P* \< 0.05. For peptide identification by liquid chromatography-tandem mass spectrometry (LC-MS/MS) using iTRAQ labeled peptides, all spectra were analyzed with Proteome Discoverer (version 1.4.0.29, Thermo Fisher Scientific) using a Uniprot database (<http://www.uniprot.org>) containing all sequences from Ixodida, Anaplasmataceae and Ruminantia. Peptide identification was validated using the probability ratio method and false discovery rate (FDR) was calculated using inverted databases and the refined method with an additional filtering for precursor mass tolerance of 12 ppm. Only peptides with a confidence of at least 95% were used to quantify the relative abundance of each peptide. Outliers at the scan and peptide levels and significant protein-abundance changes were detected from the *z*-values (the standardized variable used by the model that expresses the quantitative values in units of standard deviation) by using a FDR threshold of 5%. Results were the mean of two replicates. For transcriptomics and proteomics analysis in tick cells, the *I. scapularis* embryo-derived tick cell line ISE6, provided by Ulrike Munderloh, University of Minnesota, USA, was cultured in L-15B300 medium (Munderloh et al., [@B35]), except that the osmotic pressure was lowered by the addition of one-fourth sterile water by volume. The ISE6 cells were first inoculated with *A. phagocytophilum* (human NY18 isolate; Asanovich et al., [@B2])-infected HL-60 cells and maintained until infection was established and routinely passaged. Uninfected and infected cultures (*N* = 3 independent cultures with \~10^7^ cells each) were sampled at 7 days post-infection (dpi; percent infected cells 71--77%; Ave ± *SD*, 74 ± 3). Transcriptomics data was obtained as described above for nymphs and adult female ticks. Two biological replicates were used for each of uninfected and infected tick cells and genes differentially expressed in response to *A. phagocytophilum* infection were selected with *P* ≤ 0.05. The proteomics analysis followed the same pipeline describe above in ticks and the MS/MS raw files generated with Xcalibur (version 2.1, Thermo Fisher Scientific) were searched against a compiled database containing all sequences from Ixodida and Anaplasmataceae (<http://www.uniprot.org>). Three biological replicates were used for each of uninfected and infected tick cells. For the quantitative analysis of tick proteins, after discarding *Anaplasma* proteins in infected cells, the total number of peptide-spectrum matches (PSMs) for each tick protein were normalized against the total number of PSMs in tick cells and compared between control and infected cells by Chi2-test (*P* ≤ 0.05). Although the percent of infected ticks and cultured cells was determined as described above, the bacterial load on these samples was not considered in the analysis.

The identified genes in the carbohydrate metabolic pathways were searched against the transcriptomics and proteomics data to characterize their mRNA and protein levels in response to *A. phagocytophilum* infection.

Tertiary structure modeling and optimization
--------------------------------------------

The tertiary structures of the partial protein sequences of *I. scapularis* hypoxia-inducible factor 1 alpha HIF-1α (XP_002414889) and HIF-1β (XP_002416629) proteins, which are the DNA binding N-terminus domains, were modeled using the Swiss-Model server (Biasini et al., [@B10]). The tertiary models were optimized using the Protein Preparation Wizard (Li et al., [@B32]) in the Schrödinger\'s Maestro software package. The Protein Preparation Wizard clusters at the highest degree of hydrogen bonding in equilibrium. Monte Carlo orientations are performed (100,000) for each cluster. The optimized structure is based on electrostatic and geometric scoring functions. Any remaining steric clashes were eliminated by minimization of the entire system with the default settings in the Schrodinger\'s Maestro package. The ternary structure that includes the hypoxia response element (HRE) was constructed via superimposition by using the Swiss-Model server used the mouse HIF-1α, HIF-1β, and the HRE (Dalei et al., [@B16]) as a template for both *I. scapularis* hypoxia-inducible protein sequences. As a final optimization step, the ternary structure (HIF-1α/HIF-1β/HRE) was processed using the normal mode ready-made script in the Metropolis Monte Carlo-based Protein Energy Landscape Exploration (PELE) server (Borrelli et al., [@B12]). The PELE software implements an anisotropic network model (Atilgan et al., [@B3]) for perturbations of the alpha-carbon backbone causing structural conformational changes. The PELE server can be accessed at <https://pele.bsc.es/>.

Immunofluorescence assay in *I. scapularis* midguts and salivary glands
-----------------------------------------------------------------------

Female ticks fed on *A. phagocytophilum*-infected and uninfected sheep and fixed with 4% paraformaldehyde in 0.2 M sodium cacodylate buffer were embedded in paraffin and used to prepare sections on glass slides as previously described (Ayllón et al., [@B6]). The paraffin was removed from the sections through two washes in xylene and the sections were hydrated by successive 5 min washes with a graded series of 100, 96, and 65% ethanol and finally with distilled water. Next, the slides were treated with Proteinase K (Dako, Barcelona, Spain) for 7 min, washed with 0,1% PBS-Tween 20 (Sigma-Aldrich, St. Louis, MI, USA) and blocked with 2% bovine serum albumin (BSA; Sigma-Aldrich) in PBS-Tween 20 during 1 h at room temperature. The slides were then incubated overnight at 4°C with mouse anti-Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) monoclonal antibodies (ab50567; Abcam, Cambridge, UK) diluted 1:100 in 2% BSA/PBS-Tween 20. Preimmune serum was used as control. After 3 washes with PBS-Tween 20, the slides were incubated for 1 h with rabbit anti-mouse IgG conjugated with FITC (Sigma-Aldrich) diluted 1:160 in 2% BSA/PBS-Tween 20. Finally, after two washes with PBS the slides were mounted on ProLong Diamond Antifade Mountant with DAPI reagent (Thermo Scientific, Madrid, Spain). The sections were examined using a Zeiss LSM 800 with Airyscan (Carl Zeiss, Oberkochen, Germany).

Infected and uninfected cultured ISE6 tick cells
------------------------------------------------

The *I. scapularis* embryo-derived tick cell line ISE6 were cultured as described above, infected with *A. phagocytophilum* (human NY18 isolate; Asanovich et al., [@B2]) or mock-infected and maintained according to Munderloh et al. ([@B35]).

Pharmacological studies in cultured ISE6 tick cells
---------------------------------------------------

*A. phagocytophilum*-infected ISE6 cells were left untreated or treated for 24 or 48 h with 5 mM 2-Deoxy-D-Glucose (ab142242, Abcam) to inhibit glycolysis (Wang et al., [@B43]), 100 μM LY294002 (ab120243, Abcam) to inhibit the phosphatidylinositol 3-kinase (PI3K; Sultana et al., [@B41]), 100 nM Chetomin (ab144222, Abcam) to inhibit the activity of HIF-1α (Misra et al., [@B34]) or 0.5 mM Deferoxamine mesylate (Sigma-Aldrich) to activate HIF-1α (Choi et al., [@B15]). After treatment, cells were harvested for the preparation of whole cell lysates to determine HIF-1α activity and for DNA extraction. Tick cell lysates were prepared by adding to cell pellets the RIPA lysis buffer (Thermo Scientific) supplemented with a protease inhibitor cocktail (cOmplete Mini, EDTA-free, Roche, Sigma-Aldrich). HIF-1α activity was determined in the cell lysate supernatants with the HIF-1 alpha Transcription Factor Assay Kit (ab133104, Abcam) following manufacturer\'s recommendations. *A. phagocytophilum* DNA levels were characterized by *msp4* real-time PCR normalizing against tick *16S rDNA* as described previously (Ayllón et al., [@B5]). Optical density values (O.D. 450 nm) for HIF-1α activity and normalized Ct values for *A. phagocytophilum* DNA levels were compared between treated and untreated control cells by Student\'s *t*-test with unequal variance (*P* = 0.05; *N* = 4 biological replicates).

Results {#s3}
=======

Major carbohydrate metabolic pathways described in other organisms are present in *I. scapularis* and are affected by *A. phagocytophilum* infection
----------------------------------------------------------------------------------------------------------------------------------------------------

Seven major pathways involved in carbohydrate metabolism were selected for characterization (Table [1](#T1){ref-type="table"}). A total of 79 genes coding for the proteins involved in glycolysis, gluconeogenesis, pentose phosphate pathway (PPP), glyceroneogenesis, TCA, mitochondrial oxidative phosphorylation (OXPHOS) and β-oxidation were identified in the *I. scapularis* genome (Table [1](#T1){ref-type="table"}). Based on these results, a model for glucose metabolism in ticks was proposed (Figure [1](#F1){ref-type="fig"}). At least in humans, pyruvate carboxylase (PC) catalyzes the irreversible carboxylation of pyruvate to form oxaloacetate, which is then transformed in phosphoenolpyruvate by the cytoplasmic enzyme phosphoenolpyruvate carboxykinase (PEPCK-C; Berg et al., [@B9]). However, the PC orthologue was not identified in the *I. scapularis* genome.

###### 

**Annotation of carbohydrate metabolic enzymes identified in the ***I. scapularis*** genome**.

  **Enzymes**                                                                                **Abbreviation**   **Genome accession**       **GenBank ID**         **Length (amino acids)**
  ------------------------------------------------------------------------------------------ ------------------ -------------------------- ---------------------- --------------------------
  **GLYCOLYSIS (GLY)**                                                                                                                                            
  Hexokinase                                                                                 HXK                [ISCW012387](ISCW012387)   [EEC16047](EEC16047)   454
  Phosphoglucose isomerase                                                                   PGI                [ISCW014868](ISCW014868)   [EEC19698](EEC19698)   543
  Phosphofructokinase                                                                        PFK                [ISCW014412](ISCW014412)   [EEC18711](EEC18711)   55
  Fructose-bisphosphate aldolase A                                                           ALDA               [ISCW011371](ISCW011371)   [EEC14101](EEC14101)   364
  Glyceraldehyde 3-phosphate dehydrogenase                                                   GAPDH              [ISCW018700](ISCW018700)   [EEC07171](EEC07171)   334
  Phosphoglycerate kinase 1                                                                  PGK1               [ISCW015616](ISCW015616)   [EEC01763](EEC01763)   415
  Phosphoglycerate mutase (cofactor-independent)                                             iPGM               [ISCW020443](ISCW020443)   [EEC12432](EEC12432)   510
  Enolase                                                                                    ENOL               [ISCW017666](ISCW017666)   [EEC06821](EEC06821)   199
  Pyruvate kinase                                                                            PK                 [ISCW020197](ISCW020197)   [EEC12307](EEC12307)   538
  **GLUCONEOGENESIS (GLN)**                                                                                                                                       
  Glucose 6-phosphatase (1)                                                                  G6Pase (1)         [ISCW017459](ISCW017459)   [EEC03691](EEC03691)   356
  Glucose 6-phosphatase (2)                                                                  G6Pase (2)         [ISCW018612](ISCW018612)   [EEC07273](EEC07273)   282
  Fructose-1,6-bisphosphatase                                                                FBP                [ISCW005292](ISCW005292)   [EEC07486](EEC07486)   338
  Phosphoenolpyruvate carboxykinase mitochondrial (1)                                        PEPCK-M (1)        [ISCW001902](ISCW001902)   [EEC03297](EEC03297)   503
  Phosphoenolpyruvate carboxykinase mitochondrial (2)                                        PEPCK-M (2)        [ISCW000524](ISCW000524)   [EEC01808](EEC01808)   288
  Phosphoenolpyruvate carboxykinase 1 cytoplasmatic                                          PEPCK-C            [ISCW001905](ISCW001905)   [EEC03300](EEC03300)   165
  Phosphoenolpyruvate carboxykinase                                                          PEPCK              [ISCW008211](ISCW008211)   [EEC10279](EEC10279)   192
  Pyruvate carboxylase                                                                       PC                 Not found                  Not found              ...
  **PENTOSE PHOSPHATE PATHWAY (PPP)**                                                                                                                             
  Glucose 6-phosphate dehydrogenase                                                          G6PD               [ISCW010043](ISCW010043)   [EEC13253](EEC13253)   523
  6-phosphogluconolactonase                                                                  PGLS               [ISCW002068](ISCW002068)   [EEC04321](EEC04321)   101
  6-phosphogluconate dehydrogenase                                                           6PGD               [ISCW010101](ISCW010101)   [EEC12854](EEC12854)   507
  Ribose 5-Phosphate Isomerase                                                               RPI                [ISCW012092](ISCW012092)   [EEC16597](EEC16597)   172
  Ribulose 5-Phosphate 3-Epimerase                                                           RPPE               [ISCW001125](ISCW001125)   [EEC01731](EEC01731)   236
  Transketolase                                                                              TKT                Not found                  Not found              ...
  Transaldolase                                                                              TALDO              [ISCW023506](ISCW023506)   [EEC20008](EEC20008)   219
  **TRICARBOXYLIC ACID CYCLE (TCA CYCLE)**                                                                                                                        
  Pyruvate dehydrogenase E1                                                                  PDE1               [ISCW019126](ISCW019126)   [EEC09108](EEC09108)   393
  Citrate synthase                                                                           CS                 [ISCW009586](ISCW009586)   [EEC13404](EEC13404)   471
  Aconitase                                                                                  ACON               [ISCW010818](ISCW010818)   [EEC15463](EEC15463)   65
  Isocitrate dehydrogenase 3 α subunit                                                       IDH3A              [ISCW004116](ISCW004116)   [EEC06101](EEC06101)   362
  Isocitrate dehydrogenase 3 β subunit                                                       IDH3B              [ISCW018585](ISCW018585)   [EEC07698](EEC07698)   207
  Isocitrate dehydrogenase 3 γ-subunit (I)                                                   IDH3G1             [ISCW022614](ISCW022614)   [EEC16834](EEC16834)   132
  Isocitrate dehydrogenase 3 γ-subunit (II)                                                  IDH3G2             [ISCW017423](ISCW017423)   [EEC04192](EEC04192)   365
  2-oxoglutarate dehydrogenase E1                                                            OXOE1              [ISCW021407](ISCW021407)   [EEC14367](EEC14367)   831
  GTP/ATP-specific Succinyl-CoA synthetase---α subunit                                       B/A-SCS-α          [ISCW020686](ISCW020686)   [EEC11198](EEC11198)   217
  ATP-specific Succinyl-CoA synthetase---β subunit                                           A-SCS-β            [ISCW011750](ISCW011750)   [EEC14163](EEC14163)   425
  GTP-specific Succinyl-CoA synthetase---β subunit                                           G-SCS-β            [ISCW015999](ISCW015999)   [EEC00562](EEC00562)   422
  Succinate dehydrogenase flavoprotein subunit                                               SDHA               [ISCW000555](ISCW000555)   [EEC02042](EEC02042)   608
  Succinate dehydrogenase iron-sulfur subunit                                                SDHB               [ISCW018067](ISCW018067)   [EEC06202](EEC06202)   286
  Succinate dehydrogenase cytochrome b560 subunit                                            SDHC               [ISCW020744](ISCW020744)   [EEC12476](EEC12476)   132
  Succinate dehydrogenase cytochrome b small subunit                                         SDHD               [ISCW012012](ISCW012012)   [EEC15988](EEC15988)   208
  Fumarase hydratase mitochondrial                                                           FH                 [ISCW020593](ISCW020593)   [EEC13182](EEC13182)   481
  Malate dehydrogenase 1 cytoplasmatic                                                       MDH1               [ISCW007624](ISCW007624)   [EEC09194](EEC09194)   302
  Malate dehydrogenase 2 mitochondrial                                                       MDH2               [ISCW003528](ISCW003528)   [EEC05916](EEC05916)   340
  **REGULATORY PROTEINS OF TCA CYCLE**                                                                                                                            
  Pyruvate dehydrogenase kinase                                                              PDK                [ISCW013649](ISCW013649)   [EEC19175](EEC19175)   344
  Pyruvate dehyrogenase phosphatase catalytic subunit 1                                      PDPC1              [ISCW014874](ISCW014874)   [EEC19704](EEC19704)   401
  **OXIDATIVE PHOSPHORYLATION (OXPHOS) COMPLEX I (CORE SUBUNITS)**                                                                                                
  NADH dehydrogenase (ubiquinone) iron-sulfur protein 7                                      NDUS7              [ISCW013042](ISCW013042)   [EEC17810](EEC17810)   162
  NADH dehydrogenase (ubiquinone) iron-sulfur protein 8                                      NDUS8              [ISCW010554](ISCW010554)   [EEC13775](EEC13775)   210
  NADH dehydrogenase (ubiquinone) flavoprotein 2                                             NDUV2              [ISCW014272](ISCW014272)   [EEC18480](EEC18480)   244
  NADH dehydrogenase (ubiquinone) iron-sulfur protein 3                                      NDUS3              [ISCW012366](ISCW012366)   [EEC17298](EEC17298)   268
  NADH dehydrogenase (ubiquinone) iron-sulfur protein 2                                      NDUS2              [ISCW017643](ISCW017643)   [EEC06293](EEC06293)   462
  NADH dehydrogenase (ubiquinone) flavoprotein 1                                             NDUV1              [ISCW005985](ISCW005985)   [EEC08296](EEC08296)   477
  NADH-ubiquinone oxidoreductase 75 kDa subunit                                              NDUS1              [ISCW003299](ISCW003299)   [EEC03949](EEC03949)   729
  NADH-ubiquinone oxidoreductase chain 1                                                     ND1                [ISCW016073](ISCW016073)   [EEC02134](EEC02134)   339
  NADH-ubiquinone oxidoreductase chain 2                                                     ND2                Not found                  Not found              ...
  NADH-ubiquinone oxidoreductase chain 3                                                     ND3                Not found                  Not found              ...
  NADH-ubiquinone oxidoreductase chain 4                                                     ND4                Not found                  Not found              ...
  NADH-ubiquinone oxidoreductase chain 4L                                                    ND4L               Not found                  Not found              ...
  NADH-ubiquinone oxidoreductase chain 5                                                     ND5                [ISCW016735](ISCW016735)   [EEC02838](EEC02838)   385
  NADH-ubiquinone oxidoreductase chain 6                                                     ND6                Not found                  Not found              ...
  **OXPHOS COMPLEX II**                                                                                                                                           
  Succinate dehydrogenase flavoprotein subunit                                               SDHA               [ISCW000555](ISCW000555)   [EEC02042](EEC02042)   608
  Succinate dehydrogenase iron-sulfur subunit                                                SDHB               [ISCW018067](ISCW018067)   [EEC06202](EEC06202)   286
  Succinate dehydrogenase cytochrome b560 subunit                                            SDHC               [ISCW020744](ISCW020744)   [EEC12476](EEC12476)   132
  Succinate dehydrogenase cytochrome b small subunit                                         SDHD               [ISCW012012](ISCW012012)   [EEC15988](EEC15988)   208
  **OXPHOS COMPLEX III**                                                                                                                                          
  Cytochrome b-c1 complex subunit 1                                                          QCR1               Not found                  Not found              ...
  Cytochrome b-c1 complex subunit 2                                                          QCR2               Not found                  Not found              ...
  Cytochrome b                                                                               CYTB               [ISCW016730](ISCW016730)   [EEC02834](EEC02834)   385
  Cytochrome c1                                                                              CYTC1              [ISCW016731](ISCW016731)   [EEC02835](EEC02835)   251
  Cytochrome b-c1 complex subunit Rieske                                                     RIESKE             [ISCW014071](ISCW014071)   [EEC19414](EEC19414)   229
  Cytochrome b-c1 complex subunit 6                                                          QCR6               [ISCW017835](ISCW017835)   [EEC05133](EEC05133)   80
  Cytochrome b-c1 complex subunit 7                                                          QCR7               [ISCW012532](ISCW012532)   [EEC17642](EEC17642)   81
  Cytochrome b-c1 complex subunit 8                                                          QCR8               [ISCW019560](ISCW019560)   [EEC09147](EEC09147)   82
  Cytochrome b-c1 complex subunit 9                                                          QCR9               [ISCW008376](ISCW008376)   [EEC10144](EEC10144)   59
  Cytochrome b-c1 complex subunit 10                                                         QCR10              Not found                  Not found              ...
  Cytochrome b-c1 complex subunit 11                                                         QCR11              Not found                  Not found              ...
  **OXPHOS COMPLEX IV**                                                                                                                                           
  Cytochrome c oxidase subunit 1                                                             COX1               Not found                  [ADO64507](ADO64507)   276
  Cytochrome c oxidase subunit 2                                                             COX2               [ISCW016021](ISCW016021)   [EEC02091](EEC02091)   244
  Cytochrome c oxidase subunit 3                                                             COX3               [ISCW020757](ISCW020757)   [EEC11360](EEC11360)   278
  Cytochrome c oxidase subunit 4                                                             COX4               Not found                  [AAY66918](AAY66918)   179
  Cytochrome c oxidase subunit 5A                                                            COX5A              [ISCW008682](ISCW008682)   [EEC12772](EEC12772)   153
  Cytochrome c oxidase subunit 5B                                                            COX5B              [ISCW019526](ISCW019526)   [EEC10693](EEC10693)   124
  Cytochrome c oxidase subunit 6A                                                            COX6A              [ISCW019235](ISCW019235)   [EEC08541](EEC08541)   111
  Cytochrome c oxidase subunit 6B                                                            COX6B              [ISCW015139](ISCW015139)   [EEC20473](EEC20473)   82
  Cytochrome c oxidase subunit 6C                                                            COX6C              [ISCW016559](ISCW016559)   [EEC02407](EEC02407)   76
  Cytochrome c oxidase subunit 7                                                             COX7               Not found                  Not found              ...
  Cytochrome c oxidase subunit 8                                                             COX8               [ISCW024928](ISCW024928)   [EEC20083](EEC20083)   68
  **OXPHOS COMPLEX V (ATP SYNTHASE: F1-ATP SYNTHASE STRUCTURE/F0-ATP SYNTHASE STRUCTURE)**                                                                        
  ATP synthase subunit α 1 (F1)                                                              ATPSA1             [ISCW011988](ISCW011988)   [EEC16574](EEC16574)   555
  ATP synthase subunit α 2 (F1)                                                              ATPSA2             [ISCW019217](ISCW019217)   [EEC08626](EEC08626)   355
  ATP synthase subunit β (F1)                                                                ATPSB              [ISCW012509](ISCW012509)   [EEC17118](EEC17118)   563
  ATP synthase subunit γ (F1)                                                                ATPSG              [ISCW023477](ISCW023477)   [EEC19169](EEC19169)   314
  ATP synthase subunit δ (F1)                                                                ATPSD              [ISCW018418](ISCW018418)   [EEC06183](EEC06183)   168
  ATP synthase subunit ϵ (F1)                                                                ATPSE              [ISCW022265](ISCW022265)   [EEC17228](EEC17228)   55
  ATP synthase subunit A (F0)                                                                ATPA               Not found                  Not found              ...
  ATP synthase subunit B (F0)                                                                ATPB               [ISCW012060](ISCW012060)   [EEC15991](EEC15991)   264
  ATP synthase subunit C (F0)                                                                ATPC               [ISCW010495](ISCW010495)   [EEC14551](EEC14551)   152
  **β-OXIDATION**                                                                                                                                                 
  Acyl-CoA dehydrogenase family member 9                                                     ACAD9              [ISCW010038](ISCW010038)   [EEC13248](EEC13248)   433
  Short-chain specific acyl-CoA dehydrogenase (1)                                            SCAD1              [ISCW013995](ISCW013995)   [EEC19715](EEC19715)   76
  Short-chain specific acyl-CoA dehydrogenase (2)                                            SCAD2              [ISCW002863](ISCW002863)   [EEC02614](EEC02614)   410
  Medium-chain acyl-CoA dehydrogenase                                                        MCAD               [ISCW001274](ISCW001274)   [EEC01138](EEC01138)   275
  Very long-chain acyl-CoA dehydrogenase                                                     VLCAD              [ISCW024772](ISCW024772)   [EEC16420](EEC16420)   254
  Enoyl-CoA hydratase                                                                        ECHD               [ISCW012475](ISCW012475)   [EEC16250](EEC16250)   290
  3-hydroxyacyl CoA dehydrogenase                                                            3HCD               [ISCW014460](ISCW014460)   [EEC18745](EEC18745)   310
  3-ketoacyl-CoA thiolase (Thiolase I)                                                       THIOL              [ISCW022661](ISCW022661)   [EEC17467](EEC17467)   406
  **GLYCERONEOGENESIS**                                                                                                                                           
  Triosephosphate isomerase                                                                  TPI                [ISCW008869](ISCW008869)   [EEC13429](EEC13429)   247
  Glycerol-3-phosphate dehydrogenase cytoplasmic                                             GPDHc              [ISCW005254](ISCW005254)   [EEC07468](EEC07468)   340

![**Model of carbohydrate metabolism in ***I. scapularis*****. The main enzymes involved in Glycolysis (GLY), Gluconeogenesis (GLN), Pentose phosphate pathway (PPP), Tricarboxylic acid cycle (TCA), Oxidative phosphorylation (OXPHOS) complex I to V, β-Oxidation and Glyceroneogenesis (GLYCENEO) and present in the genome of *I. scapularis* (Table [1](#T1){ref-type="table"}) are shown. The names and number of carbon molecules (Red circles) of the metabolic intermediates of these metabolic pathways are also shown. The names of the enzymes were abbreviated for the different pathways as GLY: Hexokinase (HXK), Phosphoglucose isomerase (PGI), Phosphofructokinase (PFK), Fructose-bisphosphate aldolase A (ALDA), Glyceraldehyde 3-phosphate dehydrogenase (GAPDH), Phosphoglycerate kinase 1 (PGK1), Phosphoglycerate mutase (cofactor-independent) (iPGM), Enolase (ENOL), Pyruvate kinase (PK); GLN: Glucose 6-phosphatase (1) (G6Pase (1)), Fructose-1,6-bisphosphatase (FBP), Phosphoenolpyruvate carboxykinase mitochondrial (1) (PEPCK-M (1)), Phosphoenolpyruvate carboxykinase mitochondrial (2) (PEPCK-M (2)), Phosphoenolpyruvate carboxykinase 1 cytoplasmatic (PEPCK-C), Pyruvate carboxylase (PC); PPP: Glucose 6-phosphate dehydrogenase (G6PD), 6-phosphogluconolactonase (PGLS), 6-phosphogluconate dehydrogenase (6PGD), Ribose 5-Phosphate Isomerase (RPI), Ribulose 5-Phosphate 3-Epimerase (RPPE), Transketolase (TKT), Transaldolase (TALDO); β-Oxidation: Acyl-CoA dehydrogenase family member 9 (ACAD9), Short-chain specific acyl-CoA dehydrogenase (1) (SCAD1), Short-chain specific acyl-CoA dehydrogenase (2) (SCAD2), Medium-chain acyl-CoA dehydrogenase (MCAD), Very long-chain acyl-CoA dehydrogenase (VLCAD), Enoyl-CoA hydratase (ECHD), 3-hydroxyacyl CoA dehydrogenase (3HCD), 3-ketoacyl-CoA thiolase (Thiolase I) (THIOL); GLYCENEO: Triosephosphate isomerase (TPI), Glycerol-3-phosphate dehydrogenase cytoplasmic (GPDHc); OXPHOS: Complex I: NADH dehydrogenases (NDUS7, NDUS8, NDUV2, NDUS3, NDUS2 and NDUV1), NADH-ubiquinone oxidoreductases (NDUS1, ND1 and ND5); Complex II: Succinate dehydrogenases (SDHA, SDHB, SDHC, SDHD); Complex III: Cytochrome b and b-c1 complexe subunits (QCR1, QCR2, CYTB, RIESKE, QCR6, QCR7, QCR8, QCR9, QCR10, QCR11), Cytochrome c1 (CYTC1); Complex IV: Cytochrome c oxidase subunits (COX1, COX2, COX3, COX5A, COX5B, COX6A, COX6B, COX6C, COX8); Complex V: ATP synthase subunits (ATPSA1, ATPSA2, ATPSB, ATPSG, ATPSD, ATPSE, ATPB, ATPC).](fcimb-07-00023-g0001){#F1}

The carbohydrate metabolic response to *A. phagocytophilum* infection was then characterized using the quantitative transcriptomics and proteomics data generated from uninfected and *A. phagocytophilum*-infected *I. scapularis* ticks and ISE6 cultured cells (Ayllón et al., [@B6]; Villar et al., [@B42]). Most of the identified carbohydrate metabolism genes were differentially regulated in response to *A. phagocytophilum* infection in at least one of the analyzed tick tissues (Figure [2](#F2){ref-type="fig"}). Twenty-eight (35%), 23 (29%), 62 (78%), and 64 (81%) carbohydrate metabolism components were identified in both transcriptome and proteome of ISE6 cells, nymphs, adult female midguts, and salivary glands, respectively (Figure [2](#F2){ref-type="fig"}). Of these genes, 59 (75%), 14 (18%), 60 (76%), and 41 (52%) were up-regulated, while 20 (25%), 65 (82%), 16 (20%), and 35 (44%) were down-regulated in response to infection in ISE6 cells, nymphs, adult female midguts, and salivary glands, respectively (Figure [2](#F2){ref-type="fig"}). Many of the carbohydrate metabolism proteins were not identified by mass spectrometry (Figure [2](#F2){ref-type="fig"}), but the results showed similar differential regulation at the mRNA and protein levels for 50% of the identified proteins.

![*****I. scapularis*** carbohydrate metabolism enzymes mRNA and protein levels in response to ***A. phagocytophilum*** infection**. Comparison of carbohydrate metabolism enzymes mRNA and protein levels in *I. scapularis* nymphs (N), female midguts (G), female salivary glands (SG), and ISE6 cells (ISE6) in response to *A. phagocytophilum* infection. Transcriptomics and proteomics data were obtained from previously published datasets available on the Dryad repository database, NCBI\'s Gene Expression Omnibus database and ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier [PXD002181](PXD002181) and doi: 10.6019/PXD002181 (Ayllón et al., [@B6]; Villar et al., [@B42]). Name of enzymes are abbreviated as in Table [1](#T1){ref-type="table"} and Figure [1](#F1){ref-type="fig"}.](fcimb-07-00023-g0002){#F2}

Glucose transporters, and mainly facilitative glucose transporters (GLUT) are an important component of the glycolytic pathway because they transport glucose from the extracellular space to the cellular cytoplasm, which makes the glucose accessible to hexokinase (HXK; Augustin, [@B4]; Li et al., [@B31]). We found 11 putative glucose transporters in the genome of *I. scapularis*, 2 members (*sglt1* and *sglt2*) of the sodium-glucose linked transporter family (SGLT), and 9 members (2 isoforms of *glut1, glut3*, 4 isoforms of *glut8, glut10*, and *glut12*) of the GLUT family. In response to *A. phagocytophilum* infection, *glut1B, glut3, glut8C, glut10, glut12*, and *sglt1* genes were up-regulated in tick midguts, and the GLUT1A and SGLT2 proteins were over-represented in infected midguts when compared to uninfected controls (Figure [3](#F3){ref-type="fig"}).

![*****I. scapularis*** glucose transporters mRNA and protein levels in response to ***A. phagocytophilum*** infection**. Comparison of glucose transporters mRNA and protein levels in *I. scapularis* nymphs (N), female midguts (G), female salivary glands (SG) and ISE6 cells (ISE6) in response to *A. phagocytophilum* infection. Transcriptomics and proteomics data were obtained from previously published datasets available on the Dryad repository database, NCBI\' Gene Expression Omnibus database and ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier [PXD002181](PXD002181) and doi: 10.6019/PXD002181 (Ayllón et al., [@B6]; Villar et al., [@B42]).](fcimb-07-00023-g0003){#F3}

As in previous experiments (Villar et al., [@B42]), these results supported a role for carbohydrate metabolism during *A. phagocytophilum* infection in *I. scapularis*, and suggested tissue-specific differences in response to infection.

*A. phagocytophilum* infection activates the glycolysis pathway, but reduces gluconeogenesis and the TCA cycle in tick midguts
------------------------------------------------------------------------------------------------------------------------------

Based on these results, the putative glucose metabolic pathways affected by *A. phagocytophilum* infection in different *I. scapularis* tissues and ISE6 cells were proposed (Figures [4](#F4){ref-type="fig"}, [5](#F5){ref-type="fig"}). The results showed that the genes involved in glycolysis were all up-regulated in tick midguts after *A. phagocytophilum* infection, except for phosphofructokinase (*pfk*) and *hxk* genes that did not change in response to infection (Figure [2](#F2){ref-type="fig"}). The up-regulation of glycolytic genes correlated with protein over-representation in tick midguts, except for the cofactor-independent phosphoglycerate mutase (*ipgm*) and pyruvate kinase (*pk*) that despite gene up-regulation in infected midguts, protein was under-represented in response to infection (Figure [2](#F2){ref-type="fig"}). However, since iPGM catalyzes a reversible reaction, it is not a site of major regulatory mechanisms for the glycolytic pathway. In contrast, HXK and PFK proteins, which catalyze irreversible steps of glucose glycolysis and therefore constitute major regulatory steps of this pathway, were over-represented and did not change, respectively in response to infection of tick midguts (Figure [4](#F4){ref-type="fig"}). The expression of the p53 target TP53-inducible glycolysis and apoptosis regulator (*tigar*, ISCW020485), which was recently shown to inhibit glycolysis (Bensaad et al., [@B8]), was down-regulated in tick nymphs, midguts, salivary glands, and ISE6 cells. The over-representation of all glycolytic enzymes correlated with up-regulation of their respective genes, suggesting transcriptional regulation. These data suggested that *A. phagocytophilum* infection activates glucose uptake and degradation in *I. scapularis* midguts. In agreement with an increase in glucose catabolism, the levels of glucose were significantly reduced (0.51 ± 0.06 vs. 0.31 ± 0.05, *p* \< 0.005) in infected ISE6 cells when compared to uninfected controls (Villar et al., [@B42]).

![**Carbohydrate metabolic pathways in response to ***A. phagocytophilum*** infection in ***I. scapularis*** nymphs and female midguts**. Protein representation of enzymes of the *I. scapularis* carbohydrate metabolic pathways in response to *A. phagocytophilum* infection is shown. Similar changes in mRNA and protein levels are highlighted (triangles). Code: green, up-regulated/over-represented; red, down-regulated/under-represented.](fcimb-07-00023-g0004){#F4}

![**Carbohydrate metabolic pathways in response to ***A. phagocytophilum*** infection in ***I. scapularis*** salivary glands and ISE6 cells**. Protein representation of enzymes of the *I. scapularis* carbohydrate metabolic pathways in response to *A. phagocytophilum* infection is shown. Similar changes in mRNA and protein levels are highlighted (triangles). Code: green, up-regulated/over-represented; red, down-regulated/under-represented.](fcimb-07-00023-g0005){#F5}

PK catalyzes the final irreversible step of glycolysis, the transfer of a phosphate group from phosphoenolpyruvate to ADP, yielding one molecule of pyruvate and one molecule of adenosine 5′-triphosphate (ATP; Li et al., [@B31]). This gene was up-regulated, but protein was under-represented in response to infection in tick midguts (Figures [2](#F2){ref-type="fig"}, [4](#F4){ref-type="fig"}). Due to the regulatory role of PK, low levels of this enzyme may hamper the flux of pyruvate toward the mitochondrial matrix, decreasing the activity of TCA cycle. PK generates pyruvate, which is transported to the mitochondrial matrix by mitochondrial pyruvate carriers 1 and 2 (MPC1 and MPC2). The homologs for *mpc1* and *mpc2* genes were identified in *I. scapularis* and were up-regulated in tick midguts, but down-regulated in salivary glands in response to *A. phagocytophilum* infection (Figure [3](#F3){ref-type="fig"}). In the mitochondrial matrix, pyruvate is decarboxylated by pyruvate dehydrogenase E1 (PDE1; Berg et al., [@B9]). The decarboxylation of pyruvate is the first step of a series of enzymatic reactions that transform pyruvate into acetyl coenzyme A (acetyl-Coa), which is oxidized to CO~2~ and water in the TCA cycle (Berg et al., [@B9]). PDE1 is an important regulator of the TCA cycle (Berg et al., [@B9]). Pyruvate dehydrogenase kinase 1 (PDK1) inhibits, while pyruvate dehydrogenase phosphatase catalytic subunit 1 (PDPC1) activates PDE1 (Berg et al., [@B9]). We found that in the midguts of infected ticks, PDE1 was under-represented and the genes *pdk1* and *pdpc1* were up-regulated and down-regulated, respectively in response to infection (Figure [2](#F2){ref-type="fig"}). This result strongly suggested that *A. phagocytophilum* infection inhibited the TCA cycle in *I. scapularis* midguts. In agreement with this suggestion, several TCA cycle enzymes such as citrate synthase (CS), aconitase (ACON), isocitrate dehydrogenase \[subunits α (IDH3A) and γ (IDH3G1)\], 2-oxoglutarate dehydrogenase E1 (OXOE1), succinate dehydrogenase (flavoprotein subunit (SDHA), and iron-sulfur subunit (SDHB) were under-represented in midguts from infected ticks when compared to uninfected controls (Figures [2](#F2){ref-type="fig"}, [4](#F4){ref-type="fig"}).

The NADH generated by the TCA cycle is fed into the OXPHOS pathway to produce ATP (Li et al., [@B31]). The mRNA and protein levels of components of the OXPHOS complex I--IV present in *I. scapularis* were examined. Higher mRNA and protein levels were found for most of the respiratory components in infected tick midguts when compared to uninfected controls (Figure [2](#F2){ref-type="fig"}). This result suggested that ticks might have a regulatory mechanism to maintain the levels of ATP in response to the inhibition of the TCA cycle.

Finally, we found that although most genes were up-regulated, all proteins of gluconeogenesis (synthesis of glucose from non-carbohydrate precursors) were under-represented in tick midguts, except for fructose-1,6-bisphosphatase (FBP; Figure [2](#F2){ref-type="fig"}). FBP catalyzes an irreversible reaction in the gluconeogenesis, the conversion of fructose 1,6-bisphosphate into fructose 6-phosphate, and therefore it is a regulatory step of this anabolic pathway. However, the enzyme glucose 6-phosphatase that catalyzes the last step of gluconeogenesis, the transformation of glucose 6-phosphate into free glucose was under-represented. These results suggested that midgut cells in *A. phagocytophilum*-infected ticks tend to keep glucose 6-phosphate within the cells for other metabolic processes (e.g., glycogen synthesis).

HIF-1 components are up-regulated in *I. scapularis* infected with *A. phagocytophilum*
---------------------------------------------------------------------------------------

HIF-1 is a heterodimeric transcription factor consisting of a constitutively expressed β-subunit (HIF-1β) and an oxygen-regulated α-subunit (HIF-1α; Pagé et al., [@B36]; Déry et al., [@B21]; Ziello et al., [@B46]; Badeaux and Shi, [@B7]). The gene encoding for HIF-1α (ISCW023657), which is a major transcriptional activator of glycolytic genes (Hu et al., [@B27]), was significantly up-regulated in tick midguts, but not in nymphs, salivary glands or ISE6 cells in response to *A. phagocytophilum* infection (Ayllón et al., [@B6]; Villar et al., [@B42]). The expression of the gene encoding for the HIF-1β (ISCW023999), which is a molecular partner of HIF-1α, was up-regulated in midguts from infected ticks, but was down-regulated in nymphs and did not change in salivary glands and ISE6 cells in response to infection (Ayllón et al., [@B6]; Villar et al., [@B42]).

Both *I. scapularis* HIF-1α and HIF-1β (a.k.a, aryl hydrocarbon receptor nuclear translocator or ARNT) possess the conserved basic helix-loop-helix (bHLH) domain and two PAS domains (Figures [6A,B](#F6){ref-type="fig"}). The bHLH domain of HIF-1α and HIF-1β were highly conserved with identical interacting residues as those previously identified (Dalei et al., [@B16]). The PAS-B domain of HIF-1α was disordered due to its low conservation and the presence of small insertions and deletions when compared to the mouse HIF-1α (Dalei et al., [@B16]). The PAS-B of HIF-1α interacts with both the PAS domain of HIF-1β, thereby making it difficult to determine interacting residues. One key feature of HIF-1α is the presence of two residues lysine (Lys) and glycine (Gly), which interact with the nucleotides of hypoxia response element (HRE; Dalei et al., [@B16]). The *I. scapularis* HIF-1α had the conserved Lys, but showed an asparagine (Asn) to Gly substitution (Figure [6](#F6){ref-type="fig"}).

![**Modeling of the HIF-1α-HIF-1β-HRE complex**. **(A)** HIF-1α (red) and HIF-1β (green) monomers with their respective domains labeled. **(B)** Ternary complex of both monomers plus the hypoxia response element (HRE; orange). The inset shows the conserved Lys residue that interacts with the thymine (T) of HRE.](fcimb-07-00023-g0006){#F6}

The PI3K/Akt pathway is present in *I. scapularis* and regulated in response to *A. phagocytophilum* infection
--------------------------------------------------------------------------------------------------------------

It has been demonstrated that a number of non-hypoxic stimuli are highly capable of inducing the expression of *hif-1* (Pagé et al., [@B36]; Déry et al., [@B21]). The PI3K pathway and its downstream effectors, mTOR and p70S6 kinase (p70S6K), may induce a hypoxia-independent increase in HIF-1α levels (Déry et al., [@B21]). In addition, diacylglycerol (DAG)-sensitive protein kinases C (PKC) were shown to up-regulate *hif-1*α gene expression in a hypoxia-independent manner (Pagé et al., [@B36]; Déry et al., [@B21]). Infection with *A. phagocytophilum* activates PI3K in *I. scapularis* (Sultana et al., [@B41]). Therefore, we characterized the mRNA and protein levels of tick PI3K components in response to *A. phagocytophilum* infection.

Most PI3K-mTOR pathway components found in other organisms (Pilot-Storck et al., [@B37]) were identified in the *I. scapularis* genome (Table [2](#T2){ref-type="table"}). The tick PI3K components were differentially regulated in response to *A. phagocytophilum* infection (Figure [7](#F7){ref-type="fig"}). The *p70S6K* and PI3K components (*p85*α and *p110*α) were up-regulated in tick midguts and salivary glands in response to infection. Additionally, p70S6K and p85α proteins were over-represented in midguts from infected ticks when compared to uninfected controls (Figure [7](#F7){ref-type="fig"}). Oxygen-independent activation of *hif-1*α may involve PI3K components, p70S6K and mTOR (Déry et al., [@B21]). However, we did not find an mTOR ortholog in the *I. scapularis* genome. DAG-sensitive PKCs were also suggested to play a role in oxygen-independent activation of *hif-1*α (Pagé et al., [@B36]). Protein PKCα was found to be over-represented in tick midguts and salivary glands, while the *PKC*ε gene was up-regulated in tick midguts in response to infection.

###### 

**Annotation of PI3K-mTOR pathway components identified in the ***I. scapularis*** genome**.

  **Proteins**                                                           **Abbreviation**   **Genome accession**       **GenBank ID**         **Length (amino acids)**
  ---------------------------------------------------------------------- ------------------ -------------------------- ---------------------- --------------------------
  RAC-alpha serine/threonine-protein kinase                              AKT2               [ISCW018284](ISCW018284)   [EEC06033](EEC06033)   371
  Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit α     p110α              [ISCW014229](ISCW014229)   [EEC18977](EEC18977)   617
  Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit β     p110β              [ISCW010469](ISCW010469)   [EEC14480](EEC14480)   491
  Phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing α (1)   PI3K-C2α1          [ISCW022811](ISCW022811)   [EEC17358](EEC17358)   1638
  Phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing α (2)   PI3K-C2α2          [ISCW004026](ISCW004026)   [EEC06376](EEC06376)   1142
  Phosphatidylinositol 3-kinase regulatory subunit α                     p85α               [ISCW011707](ISCW011707)   [EEC13970](EEC13970)   427
  3- phosphoinositide-dependent protein kinase 1                         PDK1               [ISCW021115](ISCW021115)   [EEC15400](EEC15400)   521
  Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1               SHIP1              [ISCW000015](ISCW000015)   [EEC00572](EEC00572)   535
  Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase PTEN            PTEN               [ISCW021211](ISCW021211)   [EEC15363](EEC15363)   363
  Arf-GAP with GTPase, ANK repeat and PH domain-containing protein       PIKE               [ISCW014072](ISCW014072)   [EEC18950](EEC18950)   558
  Glycogen synthase kinase 3 β (2)                                       GSK3β2             [ISCW009451](ISCW009451)   [EEC11886](EEC11886)   588
  Hamartin                                                               TSC1               [ISCW023319](ISCW023319)   [EEC19233](EEC19233)   874
  Tuberin                                                                TSC2               [ISCW012320](ISCW012320)   [EEC16560](EEC16560)   429
  Serine/threonine kinase 11 (1)                                         LKB1/STK11A        [ISCW024898](ISCW024898)   [EEC19357](EEC19357)   170
  Serine/threonine kinase 11 (2)                                         LKB1/STK11B        [ISCW015294](ISCW015294)   [EEC20092](EEC20092)   293
  AMP-activated protein kinase α                                         AMPKα              [ISCW020637](ISCW020637)   [EEC13103](EEC13103)   510
  AMP-activated protein kinase β                                         AMPKβ              [ISCW021036](ISCW021036)   [EEC15614](EEC15614)   183
  AMP-activated protein kinase γ                                         AMPKγ              [ISCW010164](ISCW010164)   [EEC13342](EEC13342)   154
  Ras homolog enriched in brain                                          RHEB               [ISCW018020](ISCW018020)   [EEC05182](EEC05182)   182
  Regulatory-associated protein of mTOR                                  RAPTOR             [ISCW018753](ISCW018753)   [EEC07385](EEC07385)   995
  G protein β subunit-like                                               GβL                [ISCW002765](ISCW002765)   [EEC03813](EEC03813)   324
  Rapamycin-insensitive companion of mTOR                                RICTOR             [ISCW018420](ISCW018420)   [EEC06185](EEC06185)   987
  Phosphatidylinositol 3-kinase catalytic subunit type 3                 Vps34              [ISCW008679](ISCW008679)   [EEC12769](EEC12769)   864
  Serine/threonine-protein kinase VPS15                                  Vps15              [ISCW017661](ISCW017661)   [EEC06819](EEC06819)   1351
  Pleckstrin homology domain-containing, family O member 1               CKIP1              [ISCW021605](ISCW021605)   [EEC15223](EEC15223)   359
  Casein kinase 2 subunit α                                              CK2α               [ISCW007259](ISCW007259)   [EEC10594](EEC10594)   436
  Casein kinase 2 subunit β                                              CK2β               [ISCW014459](ISCW014459)   [EEC18744](EEC18744)   222
  Ribosomal protein S6 kinase beta-1 (p70s6 kinase)                      S6K1/p70s6K        [ISCW017390](ISCW017390)   [EEC03348](EEC03348)   344

![*****I. scapularis*** PI3K-mTOR pathway components mRNA and protein levels in response to ***A. phagocytophilum*** infection**. Comparison of PI3K-mTOR pathway components mRNA and protein levels in *I. scapularis* nymphs (N), female midguts (G), female salivary glands (SG) and ISE6 cells (ISE6) in response to *A. phagocytophilum* infection. Transcriptomics and proteomics data were obtained from previously published datasets available on the Dryad repository database, NCBI\'s Gene Expression Omnibus database and ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier [PXD002181](PXD002181) and doi: 10.6019/PXD002181 (Ayllón et al., [@B6]; Villar et al., [@B42]). Name of enzymes are abbreviated as in Table [2](#T2){ref-type="table"}. (^\*^) In this figure, PDK1 stands for 3- phosphoinositide-dependent protein kinase 1, and not Pyruvate dehydrogenase kinase 1, which is also abbreviated as PDK1.](fcimb-07-00023-g0007){#F7}

Functional studies support a role for carbohydrate metabolism during *A. phagocytophilum* infection of tick cells
-----------------------------------------------------------------------------------------------------------------

Functional studies were focused on glycolysis by targeting the process at different levels (Figures [8A,B](#F8){ref-type="fig"}). *A. phagocytophilum*-infected ISE6 cells were left untreated or treated for 24 or 48 h with 2-Deoxy-D-Glucose to inhibit glycolysis (Wang et al., [@B43]), LY294002 to inhibit the PI3K (Sultana et al., [@B41]), Chetomin to inhibit the activity of HIF-1α (Misra et al., [@B34]) or Deferoxamine mesylate to activate HIF-1α (Figures [8A,B](#F8){ref-type="fig"}). Both HIF-1α (Ayllón et al., [@B6]; Villar et al., [@B42]), which is a major transcriptional activator of glycolytic genes (Hu et al., [@B27]), and most PI3K components (Figure [7](#F7){ref-type="fig"}) were affected in response to *A. phagocytophilum* infection. The results showed that LY294002 was the only compound active in ISE6 tick cells (Figure [8A](#F8){ref-type="fig"}). The lack of effect of chetomin and Deferoxamine mesylate on tick HIF-1α activity may be due to structural differences between tick and mammalian HIF-1α. The treatment of tick cells with LY294002 for 48 h resulted in lower HIF-1α activity when compared to untreated control cells (Figure [8A](#F8){ref-type="fig"}). Treatment with LY294002 has been shown in *I. scapularis* and other organisms to inhibit the PI3K pathway (Sultana et al., [@B41]), which is involved in the induction of HIF-1α to activate the glycolysis (Déry et al., [@B21]). Therefore, the results obtained in tick cells supported a role for PI3K in HIF-1α induction in tick cells. The decrease in *A. phagocytophilum* infection after LY294002 treatment for 24 and 48 h (Figure [8B](#F8){ref-type="fig"}) provided additional support to these results. As expected from the lack of effect on HIF-1α activity after incubation of tick cells with the other compounds, treatment did not affect *A. phagocytophilum* infection in these cells. Additionally, the immunofluorescence assay of GAPDH, which was over-represented in *I. scapularis* midguts and salivary glands in response to *A. phagocytophilum* infection (Figures [4](#F4){ref-type="fig"}, [5](#F5){ref-type="fig"}), corroborated the results of the proteomics analysis in tick salivary glands (Figure [8C](#F8){ref-type="fig"}).

![**Functional analysis supports a role for glycolysis during ***A. phagocytophilum*** infection of tick cells. (A)** *A. phagocytophilum*-infected ISE6 cells were left untreated (Control) or treated for 24 or 48 h with 2-Deoxy-D-Glucose to inhibit glycolysis, LY294002 to inhibit the PI3K, Chetomin to inhibit the activity of HIF-1α or Deferoxamine mesylate to activate HIF-1α. HIF-1α activity was determined in cell lysates, and O.D. 450 nm values were shown as average + *SD* and compared between treated and untreated control cells by Student\'s *t*-test with unequal variance (*P* = 0.05; *N* = 4 biological replicates). **(B)** *A. phagocytophilum* DNA levels were characterized in LY294002-treated and untreated control cells by *msp4* real-time PCR normalizing against tick *16S rDNA*. Normalized Ct values were compared between treated and untreated control cells by Student\'s *t*-test with unequal variance (*P* \< 0.01; *N* = 4 biological replicates). **(C)** Representative images of imunofluorescence analysis of uninfected and *A. phagocytophilum*-infected adult female *I. scapularis* salivary gland acini (SG). Tick tissues were stained with preimmune control serum or mouse anti-GAPDH monoclonal antibodies (green, FITC) or DAPI (blue) and superimposed (FITC+DAPI). Bars, 20 μm. Red arrows illustrate the positive staining for GAPDH in tick SG.](fcimb-07-00023-g0008){#F8}

Discussion {#s4}
==========

Recently, Villar et al. ([@B42]) showed modifications in tick cell glucose metabolism during *A. phagocytophilum* infection. The results evidenced that infection affected the glucose metabolic pathway in tick cells through phosphoenolpyruvate carboxykinase (PEPCK) inhibition leading to decreased gluconeogenesis, which also results in the inhibition of cell apoptosis that increases pathogen infection of tick cells (Villar et al., [@B42]). Furthermore, these results provided evidence that other carbohydrate metabolic pathways are also affected by pathogen infection. Therefore, the objective of this study was the characterization of the dynamics of major carbohydrate pathways during *A. phagocytophilum* infection of *I. scapularis*.

Cellular glycolysis converts glucose to pyruvate, which enters the mitochondria where it is converted into acetyl-CoA, and is metabolized via the TCA cycle yielding reducing equivalents that are used for OXPHOS to generate ATP (Eisenreich et al., [@B23], [@B24]). TCA cycle can be also fueled by the acetyl-CoA produced via degradation of fatty acids after β-Oxidation (Eisenreich et al., [@B23]). Alternatively, glucose can be used to produce Ribose 5-phosphate, a precursor for the synthesis of nucleotides through the PPP (Berg et al., [@B9]; Figure [1](#F1){ref-type="fig"}). In addition, glyceroneogenesis uses glycerol 3-phophate, obtained from the reduction of dihydroxyacetone phosphate (glycolytic intermediate) to synthetize fatty acids, and therefore is a major link between carbohydrate metabolism and lipid metabolism (Berg et al., [@B9]; Figure [1](#F1){ref-type="fig"}).

In this study, orthologs for 79 components of major carbohydrate metabolic pathways were identified in *I. scapularis*, and their role was characterized in response to *A. phagocytophilum* infection. The analysis was focused on seven pathways including glycolysis, gluconeogenesis, PPP, glyceroneogenesis, β-Oxidation, TCA cycle, and OXPHOS. The results showed that genes involved in glycolysis were up-regulated in *I. scapularis* ticks infected with *A. phagocytophilum*. In contrast, PEPCK, which is the enzyme that catalyzes the first step of gluconeogenesis (after this step the molecules are "committed" to the pathway and will ultimately end up in the pathway\'s final product) was under-represented (Figure [2](#F2){ref-type="fig"}). However, in addition to low levels of PEPCK, low TCA cycle activity might be also necessary to control gluconeogenesis (Burgess et al., [@B13]). Interestingly, we found that several enzymes and intermediates such as succinate of the TCA cycle are also under-represented in infected tick ISE6 cells and midguts (Figures [4](#F4){ref-type="fig"}, [5](#F5){ref-type="fig"}; Villar et al., [@B42]). These results strongly suggested that upon *A. phagocytophilum* infection, glycolysis is enhanced, TCA cycle inhibited and in agreement with our previous results (Villar et al., [@B42]), gluconeogenesis is inhibited. These findings supported the idea that *A. phagocytophilum* infection might be an energy-demanding process for the tick cells and that the pathogen may benefit from glycolytic intermediates.

Intracellular bacteria trigger diverse host metabolic responses (Eisenreich et al., [@B23], [@B24]). Numerous transcriptome studies have identified some of these metabolic responses as unspecific (triggered by extracellular/intracellular and pathogenic/non-pathogenic bacteria) and are therefore called "core host responses" (Boldrick et al., [@B11]). These "core host responses" are modulated in different ways by virulence mechanisms of different bacteria species (Boldrick et al., [@B11]). For example, *in vivo* studies in mice showed that the facultative intracellular pathogen *Mycobacterium tuberculosis* induces a reduction in the levels of glucose and the TCA cycle intermediates oxaloacetate and fumarate, but also an increase in lactate and succinate concentration (Shin et al., [@B38]; Somashekar et al., [@B39]). In *Listeria monocytogenes*, Lecuit et al. ([@B30]) found that the transcription of most glycolytic genes was enhanced after infection in mice, particularly *hxk II*. The upregulation of glycolytic genes was linked to enhanced *hif-1*α expression and downregulation of the gluconeogenic gene *fbp* (Lecuit et al., [@B30]). The above examples illustrate commonalities among the host metabolic responses to *M. tuberculosis, L. monocytogenes* and *A. phagocytophilum* infection.

Based on the results of this study, a model was proposed in which *A. phagocytophilum* induces transcriptional activation of *hif-1*α through PI3K (p85α, p110α, and p70S6K) and PKC to activate the glycolytic pathway and inhibit the TCA cycle in infected ticks (Figure [9](#F9){ref-type="fig"}). This model was partially supported by functional studies using a PI3K inhibitor to monitor the effect on HIF-1α activity and pathogen infection (Figures [8A,B](#F8){ref-type="fig"}). In normoxia, HIF-1α is rapidly degraded. Therefore, *A. phagocytophilum* may have additional mechanisms to stabilize HIF-1α at normal oxygen concentrations. The increase in the levels of heat shock proteins HSP70 and HSP90 may contribute to the stabilization of HIF-1α in normoxia (Zhou et al., [@B45]). Previously, we showed that HSP70 and HSP90 were over-represented in *A. phagocytophilum*-infected ISE6 tick cells when compared to uninfected cells (Villar et al., [@B42]). Furthermore, mobilization of p300 at HIF target genes may be an additional requirement of HIF-mediated transcriptional activation (Badeaux and Shi, [@B7]). In agreement with this model, recently we showed that *A. phagocytophilum* induces the production of p300 to inhibit cell apoptosis and increase bacterial multiplication in tick cells (Cabezas-Cruz et al., [@B14]). By inhibiting the TCA cycle in host cells, *A. phagocytophilum* may inhibit the entrance of glutamine and glutamate to the TCA cycle via α-ketoglutarate, which is one of the intermediates in the TCA cycle. This process may increase the cytoplasmic concentration of glutamine and glutamate that can then be used by *A. phagocytophilum*. The TCA cycle of *A. phagocytophilum* is incomplete (because one gene for isocitrate dehydrogenase is missing from the genome) and requires the exogenous acquisition of glutamine and glutamate (Huang et al., [@B28]), which the pathogen may obtain from the host cell cytoplasm. *A. phagocytophilum* has the enzyme that converts glutamine to glutamate and glutamate can be then transformed to α-ketoglutarate that may fuel the bacterial TCA cycle.

![**Mechanistic model of carbohydrate metabolism manipulation by ***A. phagocytophilum*****. We propose a mechanism by which *A. phagocytophilum* enhances glycolysis through HIF activation under normoxic conditions. Upon contact with the host membrane or once inside the parasitophorous vacuole, *A. phagocytophilum* induces the activation of PI3K and PKC that ultimately induce the expression of heat shock proteins HSP70 and HSP90, the acetyltransferase p300 and *hif-1*α. In normoxia, HSP70 and HSP90 stabilize HIF-1α, making possible the recruitment of p300 and HIF-1α to form a complex with HIF-1β in the nucleus. This complex activates the expression of HIF-1α target genes, which include glycolytic genes and *pdk1*. This mechanism will result in the increase in glycolysis and inhibition of gluconeogenesis. Furthermore, HIF activation can also leads to actin cytoskeleton reorganization. Therefore, by activating the HIF system *A. phagocytophilum* may regulate at the same time the tick cell carbohydrate metabolism and cytoskeleton organization. Green and red lines indicate induction/activation and inhibition, respectively. Question marks indicate that we do not know whether *A. phagocytophilum* induces the activation of PI3K and PKC upon contact with the host membrane or once inside the parasitophorous vacuole. Ap, *A. phagocytophilum*; PI3K, phosphatidylinositol 3-kinase pathway; diacylglycerol (DAG)-sensitive protein kinases C (PKC); HIF, hypoxia-inducible factor; PDK1, pyruvate dehydrogenase kinase 1; GLUT, facilitative glucose transporters; PEPCK, phosphoenolpyruvate carboxykinase.](fcimb-07-00023-g0009){#F9}

Interestingly, it was recently shown that inhibition of prolyl hydroxylases, which are involved in the regulation of HIF-1α activity, induces HIF-1α-dependent cytoskeletal remodeling in endothelial cells (Weidemann et al., [@B44]). Therefore, it is possible that *A. phagocytophilum* activates HIF-1α through PI3K to regulate simultaneously the carbohydrate metabolism and cytoskeleton organization to facilitate infection and multiplication in tick cells (Figure [9](#F9){ref-type="fig"}).

The comparison of metabolic pathways between selected Anaplasmataceae showed that *Rickettsia prowazekii, Ehrlichia chaffeensis, Neorickettsia sennetsu, Wolbachia pipientis*, and *A. phagocytophilum* might not be able to actively carry out glycolysis. Therefore, glycolytic metabolic intermediates produced by host cells may be necessary for the development of these bacteria. Only those glycolysis enzymes necessary to produce glyceraldehyde-3-phosphate and dihydroxyacetone phosphate from phosphoenolpyruvate are present in the genome of these *Rickettsia* spp. (Dunning Hotopp et al., [@B22]). Therefore, phosphoenolpyruvate may be one of the glycolytic intermediates that *A. phagocytophilum* hijacks from the host cell cytoplasm. Additionally, glycerol-3-phosphate, which is a product of glyceroneogenesis, was proposed as another metabolite taken from the host by *Rickettsia* spp. (Dunning Hotopp et al., [@B22]). In agreement with this proposed model, the glyceroneogenesis enzymes triosephosphate isomerase (TPI) and glycerol-3-phosphate dehydrogenase cytoplasmic (GPDHc) were over-represented in infected tick nymphs, midguts and/or salivary glands when compared to uninfected controls.

The failure to identify *I. scapularis* orthologs for some genes may be due to the absence of these pathway components in ticks or the fact that only \~57% of the genome have been sequenced and assembled for this species (de la Fuente et al., [@B20]; Gulia-Nuss et al., [@B26]). These results were similar to those obtained before for other genes and proteins in response to *A. phagocytophilum* infection, showing tissue-specific differences in the response to pathogen infection (Ayllón et al., [@B6]). As previously discussed, these results suggested that differences between mRNA and protein levels could be due to delay between mRNA and protein accumulation which requires sampling at different time points and/or the role for post-transcriptional and post-translational modifications in the tick tissue-specific response to *A. phagocytophilum* infection (Ayllón et al., [@B6]; Villar et al., [@B42]; Cabezas-Cruz et al., [@B14]).

Conclusions {#s5}
===========

These results support that major carbohydrate metabolic pathways are conserved in ticks. *A. phagocytophilum* infection has a major impact on the regulation of carbohydrate metabolic pathways in tick cells. As a result of the studies reported here, a mechanism was proposed by which this pathogen might induce the expression and stabilization of HIF-1α to increase glycolysis, suppress TCA cycle to reduce gluconeogenesis, and regulate cytoskeleton organization (Figure [9](#F9){ref-type="fig"}). This may be achieved by a coordinated action of PI3K/PKC pathway, for induction of *hif-1*α expression, and HSP70/90 and p300, for HIF-1α stabilization. The increase in glycolysis results in the production of energy and other components that enhance pathogen infection and transmission while preserving tick fitness. The reduction in gluconeogenesis may be a cell response to limit pathogen infection, but also results in the inhibition of cell apoptosis to enhance pathogen infection and transmission. These mechanisms provided additional support for the co-evolution of tick-pathogen interactions that can produce both conflict and cooperation between them (de la Fuente et al., [@B19]). The identification of these mechanisms provided additional evidences to support that *A. phagocytophilum* uses similar strategies to infect vertebrate hosts and ticks (de la Fuente et al., [@B17]), therefore suggesting the possibility of developing strategies for a more effective control of *A. phagocytophilum* and its associated diseases by targeting similar mechanisms in both vertebrate hosts and tick vectors.
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